Prognostic impact of previous percutaneous coronary intervention in patients with diabetes mellitus and triple-vessel disease undergoing coronary artery bypass surgery

Journal of Thoracic and Cardiovascular Surgery

Volumn 134, Issue 2, 2007, Pages 470-476

  Thielmann, Matthias ^a   Neuhäuser, Markus ^a   Knipp, Stephan ^a   Kottenberg Assenmacher, Eva ^a   Marr, Anja ^a   Pizanis, Nikolaus ^a   Hartmann, Matthias ^a   Kamler, Markus ^a   Massoudy, Parwis ^a   Jakob, Heinz ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; NITRATE;

ADULT; AGED; ARTICLE; CAUSE OF DEATH; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DIABETES MELLITUS; FEMALE; GERMANY; HEART MUSCLE REVASCULARIZATION; HUMAN; MALE; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CHI-SQUARE DISTRIBUTION; COMBINED MODALITY THERAPY; CORONARY ARTERY BYPASS; CORONARY DISEASE; DIABETES MELLITUS; FEMALE; HOSPITAL MORTALITY; HUMANS; LOGISTIC MODELS; MALE; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; STENTS; TREATMENT OUTCOME;

EID: 34447645090     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2007.04.019     Document Type: Article

References (30)

1. The SoS I. Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial. Lancet 360 (2002) 965-970
2. Serruys P.W., Ong A.T.L., van Herwerden L.A., Sousa J.E., Jatene A., Bonnier J.J.R.M., et al. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J Am Coll Cardiol 46 (2005) 575-581
3. Rodriguez A.E., Baldi J., Pereira C.F., Navia J., Alemparte M., Delacasa A., et al. Five-year follow-up of the argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II). J Am Coll Cardiol 46 (2005) 582-588
4. Hoffman S.N., TenBrook Jr. J.A., Wolf M.P., Pauker S.G., Salem D.N., and Wong J.B. A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eight-year outcomes. J Am Coll Cardiol 41 (2003) 1293-1304
5. Brener S.J., Lytle B.W., Casserly I.P., Schneider J.P., Topol E.J., and Lauer M.S. Propensity analysis of long-term survival after surgical or percutaneous revascularization in patients with multivessel coronary artery disease and high-risk features. Circulation 109 (2004) 2290-2295
6. Hannan E.L., Racz M.J., Walford G., Jones R.H., Ryan T.J., Bennett E., et al. Long-term outcomes of coronary-artery bypass grafting versus stent implantation. N Engl J Med 352 (2005) 2174-2183
7. Malenka D.J., Leavitt B.J., Hearne M.J., Robb J.F., Baribeau Y.R., Ryan T.J., et al. Comparing long-term survival of patients with multivessel coronary disease after CABG or PCI: analysis of BARI-like patients in Northern New England. Circulation 112 suppl I (2005) I371-I376
8. Pell J.P., Pell A.C.H., Jeffrey R.R., Jennings K., Oldroyd K., Eteiba H., et al. Comparison of survival following coronary artery bypass grafting vs. percutaneous coronary intervention in diabetic and non-diabetic patients: retrospective cohort study of 6320 procedures. Diabet Med 21 (2004) 790-792
9. Ben-Gal Y., Mohr R., Uretzky G., Medalion B., Hendler A., Hansson N., et al. Drug-eluting stents versus arterial myocardial revascularization in patients with diabetes mellitus. J Thorac Cardiovasc Surg 132 (2006) 861-866
10. Protocol for the bypass angioplasty revascularization investigation. Circulation 84 suppl V (1991) V1-27
11. Thielmann M., Massoudy P., Schmermund A., Neuhauser M., Marggraf G., Kamler K., et al. Diagnostic discrimination between graft-related and non-graft-related perioperative myocardial infarction with cardiac troponin I after coronary artery bypass surgery. Eur Heart J 26 (2005) 2440-2447
12. Thielmann M., Leyh R., Massoudy P., Neuhauser M., Aleksic I., Kamler M., et al. Prognostic significance of multiple previous percutaneous coronary interventions in patients undergoing elective coronary artery bypass surgery. Circulation 114 suppl I (2006) I441-I447
13. D'Agostino Jr. R.B. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 17 (1998) 2265-2281
14. Brookmeyer R., Liang K., and Linet M. Matched case-control designs and overmatched analyses. Am J Epidemiol 124 (1986) 693-701
15. Neuhäuser M., and Becher H. Improved odds ratio estimation by post hoc stratification of case-control data. Stat Med 16 (1997) 993-1004
16. Opie L.H., Commerford P.J., and Gersh B.J. Controversies in stable coronary artery disease. Lancet 367 (2006) 69-78
17. King III S.B., Dangas G., and Moses J.W. Surgery is preferred for the diabetic with multivessel disease. Circulation 112 (2005) 1500-1515
18. Taggart D.P. Coronary artery bypass grafting is still the best treatment for multivessel and left main disease, but patients need to know. Ann Thorac Surg 82 (2006) 1966-1975
19. Johnson R.G., Sirois C., Watkins J.F., Thurer R.L., Sellke F.W., Cohn W.E., et al. CABG after successful PTCA: a case-control study. Ann Thorac Surg 59 (1995) 1391-1396
20. Arjomand H., Willerson J.T., Holmes J., Bamlet W.R., Surabhi S.K., Roukoz B., et al. Outcome of Patients With Prior Percutaneous Revascularization Undergoing Repeat Coronary Intervention (from the PRESTO trial). Am J Cardiol 96 (2005) 741-746
21. Kaluza G.L., Joseph J., Lee J.R., Raizner M.E., and Raizner A.E. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol 35 (2000) 1288-1294
22. Wilson S.H., Fasseas P., Orford J.L., Lennon R.J., Horlocker T., Charnoff N.E., et al. Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting. J Am Coll Cardiol 42 (2003) 234-240
23. Vicenzi M.N., Meislitzer T., Heitzinger B., Halaj M., Fleisher L.A., and Metzler H. Coronary artery stenting and non-cardiac surgery-a prospective outcome study. Br J Anaesth 96 (2006) 686-693
24. Hassan A., Buth K.J., Baskett R.J., Ali I.S., Maitland A., Sullivan J.A., et al. The association between prior percutaneous coronary intervention and short-term outcomes after coronary artery bypass grafting. Am Heart J 150 (2005) 1026-1031
25. Gurbuz A.T., Zia A.A., Cui H., Sasmazel A., Ates G., and Aytac A. Predictors of mid-term symptom recurrence, adverse cardiac events and mortality in 591 unselected off-pump coronary artery bypass graft patients. J Card Surg 21 (2006) 28-34
26. Iakovou I., Schmidt T., Bonizzoni E., Lei G., Sangiorgi G., Stankovic G., et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293 (2005) 2126-2130
27. Gomes W.J., and Buffolo E. Coronary stenting and inflammation: implications for further surgical and medical treatment. Ann Thorac Surg 81 (2006) 1918-1925
28. Hofma S.H., van der Giessen W.J., van Dalen B.M., Lemos P.A., McFadden E.P., Sianos G., et al. Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation. Eur Heart J 27 (2006) 166-170
29. Lerman A., and Zeiher A.M. Endothelial function: cardiac events. Circulation 111 (2005) 363-368
30. Gaudino M., Cellini C., Pragliola C., Trani C., Burzotta F., Schiavoni G., et al. Arterial versus venous bypass grafts in patients with in-stent restenosis. Circulation 112 suppl I (2005) I265-I269